408 related articles for article (PubMed ID: 7658496)
1. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.
Rutqvist LE; Johansson H; Signomklao T; Johansson U; Fornander T; Wilking N
J Natl Cancer Inst; 1995 May; 87(9):645-51. PubMed ID: 7752269
[TBL] [Abstract][Full Text] [Related]
3. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy.
Sasco AJ; Chaplain G; Amoros E; Saez S
Epidemiology; 1996 Jan; 7(1):9-13. PubMed ID: 8664408
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen and risk of large bowel cancer in women with breast cancer.
Newcomb PA; Solomon C; White E
Breast Cancer Res Treat; 1999 Feb; 53(3):271-7. PubMed ID: 10369073
[TBL] [Abstract][Full Text] [Related]
6. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
Fornander T; Hellström AC; Moberger B
J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen therapy for breast cancer and endometrial cancer risk.
Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
[TBL] [Abstract][Full Text] [Related]
8. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y
Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460
[TBL] [Abstract][Full Text] [Related]
9. Association between endometrial cancer and tamoxifen treatment of breast cancer.
Peters-Engl C; Frank W; Danmayr E; Friedl HP; Leodolter S; Medl M
Breast Cancer Res Treat; 1999 Apr; 54(3):255-60. PubMed ID: 10445424
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.
Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ
Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381
[TBL] [Abstract][Full Text] [Related]
11. Endometrial and other primary cancers after tamoxifen treatment of breast cancer -- results of retrospective cohort study.
Ursic Vrscaj M; Kovacic J; Bebar S; Djurisic A; Fras PA; Robic V
Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):105-10. PubMed ID: 11267730
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer following tamoxifen therapy for breast cancer (United States).
Cook LS; Weiss NS; Pharris-Ciurej N; Schwartz SM; White E
Cancer Causes Control; 2001 Jun; 12(5):405-10. PubMed ID: 11545455
[TBL] [Abstract][Full Text] [Related]
13. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States).
Cook LS; White E; Schwartz SM; McKnight B; Daling JR; Weiss NS
Cancer Causes Control; 1996 May; 7(3):382-90. PubMed ID: 8734833
[TBL] [Abstract][Full Text] [Related]
16. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
17. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
[TBL] [Abstract][Full Text] [Related]
18. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
Robinson DC; Bloss JD; Schiano MA
Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
[TBL] [Abstract][Full Text] [Related]
20. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
Magriples U; Naftolin F; Schwartz PE; Carcangiu ML
J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
